Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03203525
What this trial is testing

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

Who this might be right for
Advanced Malignant NeoplasmColorectal Carcinoma Metastatic in the LiverMetastatic Malignant Neoplasm in the Liver+1 more
M.D. Anderson Cancer Center 38
Testing effectiveness (Phase 2)UnknownNCT01825824
What this trial is testing

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm

Who this might be right for
Hepatocellular Carcinoma
Korea Cancer Center Hospital 54
Not applicableUnknownNCT03731923
What this trial is testing

Abbreviated MRI for HCC Surveillance

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis
Seoul National University Hospital 257
Not applicableStudy completedNCT00827723
What this trial is testing

Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma

Who this might be right for
Carcinoma, HepatocellularAlcoholic CirrhosisViral Cirrhosis+1 more
University of Lausanne Hospitals 60
Testing effectiveness (Phase 2)Looking for participantsNCT04134559
What this trial is testing

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma, ChildhoodFibrolamellar CarcinomaLiver Cancer+1 more
Allison O'Neill, MD 18
Not applicableWithdrawnNCT03345225
What this trial is testing

A Clinical Study of Precision TACE (P-TACE) With Surefire

Who this might be right for
Unresectable Hepatocellular Carcinoma
University of Miami
Early research (Phase 1)Looking for participantsNCT07148050
What this trial is testing

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Who this might be right for
Solid Tumor (Excluding CNS)Liver Cell CarcinomaMalignant Rhabdoid Tumor+7 more
Seattle Children's Hospital 21
Early research (Phase 1)Study completedNCT01147380
What this trial is testing

Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation

Who this might be right for
Liver CirrhosisHepatocellular CarcinomaEvidence of Liver Transplantation
Seigo Nishida 18
Not applicableNot Yet RecruitingNCT07681817
What this trial is testing

Risk Stratification and Proactive Nursing Intervention for Acute Kidney Injury Following Interventional Therapy in Patients With Liver Cancer

Who this might be right for
Liver Cancer, Adult
Tianjin Medical University Cancer Institute and Hospital 200
Not applicableUnknownNCT05161624
What this trial is testing

Accuracy Evaluation of Artificial Intelligence Assisted Liver Tumor Ablation Path Planning

Who this might be right for
Liver Tumor
Sun Yat-sen University 160
Testing effectiveness (Phase 2)Study completedNCT06232759
What this trial is testing

TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 56
Not applicableUnknownNCT02150317
What this trial is testing

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 180
Early research (Phase 1)Study completedNCT01075113
What this trial is testing

Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
Virginia Commonwealth University 16
Testing effectiveness (Phase 2)UnknownNCT04652440
What this trial is testing

Ablation Combined With PD-1 in HCC: Phase II Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04649489
What this trial is testing

Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev

Who this might be right for
Venous Thrombosis
Jia Fan 501
Testing effectiveness (Phase 2)UnknownNCT05616390
What this trial is testing

Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02185768
What this trial is testing

Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II

Who this might be right for
Liver Cancer
Federation Francophone de Cancerologie Digestive 46
Testing effectiveness (Phase 2)Ended earlyNCT00085410
What this trial is testing

Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more
National Cancer Institute (NCI) 20
Not applicableNot Yet RecruitingNCT07379489
What this trial is testing

Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

Who this might be right for
HCCAdjuvant TherapyRecurrence+1 more
Tongji Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01581307
What this trial is testing

Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets

Who this might be right for
Liver CancerPancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 9
Next Page